We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Shield Therapeutics PLC 16 April 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Notice of Results Investor Presentation London, UK, 16 April 2024: Shield...
Shield Therapeutics PLC on Wednesday said that it was expecting stellar results for 2023, but this success was oversh ...
Shield Therapeutics PLC 21 February 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Unaudited Full Year Trading Update Full year 2023 total revenue and other...
cs PLC - Commercial-stage pharmaceutical company focused on iron deficiency product Accrufer - Hires Santosh Shanbhag ...
Shield Therapeutics PLC 09 January 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Appointment of new Chief Financial Officer Accomplished...
The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...
Shield Therapeutics PLC 07 December 2023 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Q3 2023 U.S. Commercial Highlights Continued U.S...
Shield Therapeutics PLC 27 November 2023 Shield Therapeutics plc ("Shield Therapeutics" or the "Company") PDMR Transaction Notification London, UK, 27 November 2023: Shield...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1 | -6.34920634921 | 1.575 | 1.575 | 1.475 | 3779981 | 1.51903043 | DE |
4 | -0.65 | -30.5882352941 | 2.125 | 2.2 | 1.475 | 3571097 | 1.73344064 | DE |
12 | -5.025 | -77.3076923077 | 6.5 | 6.5 | 1.475 | 6409379 | 2.82363468 | DE |
26 | -4.475 | -75.2100840336 | 5.95 | 7.65 | 1.475 | 3904838 | 3.71943814 | DE |
52 | -4.725 | -76.2096774194 | 6.2 | 12.75 | 1.475 | 3153467 | 5.58544139 | DE |
156 | -46.025 | -96.8947368421 | 47.5 | 61.5 | 1.475 | 1851988 | 11.74473994 | DE |
260 | -76.025 | -98.0967741935 | 77.5 | 201 | 1.475 | 1305468 | 20.60239642 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions